{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T05:20:19Z","timestamp":1714368019893},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.2169\/internalmedicine.3805-19","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T22:05:22Z","timestamp":1579212322000},"page":"1163-1166","source":"Crossref","is-referenced-by-count":4,"title":["Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate"],"prefix":"10.2169","volume":"59","author":[{"given":"Ryo","family":"Yamauchi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Takeyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fukunaga","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hakujuji Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunitoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Hakujuji Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kunimoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Morihara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Irie","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fukuoka University Nishijn Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shakado","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Sakisaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"},{"name":"General Medical Research Center, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Medicine, Fukuoka University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Mindikoglu AL, Regev A, Schiff ER. Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention. Clin Gastroenterol Hepatol 4: 1076-1081, 2006."},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Lok AS, McMahon BJ; Practice Guidelines Committee AAftSoLD. Chronic hepatitis B. Hepatology 34: 1225-1241, 2001.","DOI":"10.1053\/jhep.2001.29401"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kawatani T, Suou T, Tajima F, et al. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol 67: 45-50, 2001.","DOI":"10.1034\/j.1600-0609.2001.067001045.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Pattullo V. Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure. World J Hepatol 7: 954-967, 2015.","DOI":"10.4254\/wjh.v7.i7.954"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Drafting Committee for Hepatitis Management G, the Japan Society of H. JSH Guidelines for the management of hepatitis B virus infection. Hepatol Res 44(Suppl S1): 1-58, 2014.","DOI":"10.1111\/hepr.12269"},{"key":"6","unstructured":"6. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 10: 1-98, 2016."},{"key":"7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","volume":"63","author":"NA Terrault","year":"2016","unstructured":"7. Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 63: 261-283, 2016.","journal-title":"Hepatology","ISSN":"http:\/\/id.crossref.org\/issn\/0270-9139","issn-type":"print"},{"key":"8","unstructured":"8. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 67: 370-398, 2017."},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 67: 1560-1599, 2018.","DOI":"10.1002\/hep.29800"},{"key":"10","unstructured":"10. Zoppoli G, Bruzzone B, Caligiuri P, et al. From a medical mistake to a clinical warning: the case of HBV mutant virus reactivation in haematological patients. Br J Haematol 144: 969-970, 2009."},{"key":"11","unstructured":"11. Seto WK, Chan TS, Hwang YY, et al. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study. J Clin Oncol 32: 3736-3743, 2014."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Takahashi H, Ikeda M, Kumada T, et al. Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents. Hepatol Res 45: 1220-1227, 2015.","DOI":"10.1111\/hepr.12496"},{"key":"13","unstructured":"13. Yamada T, Nannya Y, Suetsugu A, et al. Late reactivation of hepatitis B virus after chemotherapies for hematological malignancies: a case report and review of the literature. Intern Med 56: 115-118, 2017."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hayashi M, Abe K, Fujita M, Okai K, Takahashi A, Ohira H. Hepatitis B virus reactivation in a patient with nonalcoholic steatohepatitis 41 months after rituximab-containing chemotherapy. Intern Med 58: 375-380, 2019.","DOI":"10.2169\/internalmedicine.1587-18"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Hui CK, Cheung WW, Zhang HY, et al. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131: 59-68, 2006.","DOI":"10.1053\/j.gastro.2006.04.015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yeo W, Zee B, Zhong S, et al. Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer 90: 1306-1311, 2004.","DOI":"10.1038\/sj.bjc.6601699"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 27: 605-611, 2009.","DOI":"10.1200\/JCO.2008.18.0182"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Hirakata A, Okumi M, Griesemer AD, et al. Reversal of age-related thymic involution by an LHRH agonist in miniature swine. Transpl Immunol 24: 76-81, 2010.","DOI":"10.1016\/j.trim.2010.08.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Holland AM, van den Brink MR. Rejuvenation of the aging T cell compartment. Curr opin Immunol 21: 454-459, 2009.","DOI":"10.1016\/j.coi.2009.06.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Goldberg GL, King CG, Nejat RA, et al. Luteinizing hormone-releasing hormone enhances T cell recovery following allogeneic bone marrow transplantation. J Immunol 182: 5846-5854, 2009.","DOI":"10.4049\/jimmunol.0801458"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/9\/59_3805-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T07:02:13Z","timestamp":1588834933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/9\/59_3805-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3805-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}